STAT3 and hepatocellular carcinoma: However, some of the STAT3 inhibitors, such as Stattic [46] and WP1066 [47] showed more effective inhibition of STAT3 activation than ODZ10117 in the in vitro results that were analyzed from breast cancer cells, hepatocellular carcinoma cells, and glioma cells.